抗癌治疗-话题@MedSci

#抗癌治疗#

18篇内容 | 687人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1934510, encodeId=c3bd193451031, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=Brit J Cancer：抗癌治疗与儿童癌症幸存者表观基因组变化有关, objectType=article, longId=723579, objectId=1408e23579ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1408e23579ac, replyNumber=0, likeNumber=54, createdTime=2022-04-20, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1408e23579ac, moduleTitle=Brit J Cancer：抗癌治疗与儿童癌症幸存者表观基因组变化有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1408e23579ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934508, encodeId=3d7b1934508e6, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=ESMO Open：接or不接？对于抗癌治疗患者，BNT162b2 COVID-19疫苗效果如何？, objectType=article, longId=216981, objectId=52da2169818b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52da2169818b, replyNumber=0, likeNumber=46, createdTime=2022-03-17, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52da2169818b, moduleTitle=ESMO Open：接or不接？对于抗癌治疗患者，BNT162b2 COVID-19疫苗效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52da2169818b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934509, encodeId=1c9b1934509ca, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=Eur J Cancer：实体癌患者抗癌治疗期间接种BNT162b2疫苗的有效性和安全性, objectType=article, longId=217136, objectId=cd3521e136d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd3521e136d9, replyNumber=0, likeNumber=53, createdTime=2022-06-15, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd3521e136d9, moduleTitle=Eur J Cancer：实体癌患者抗癌治疗期间接种BNT162b2疫苗的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd3521e136d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934507, encodeId=e476193450eda, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle= Lancet：如何选择抗癌治疗时的静脉置管？, objectType=article, longId=214554, objectId=b6c621455480, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6c621455480, replyNumber=0, likeNumber=50, createdTime=2021-10-20, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6c621455480, moduleTitle= Lancet：如何选择抗癌治疗时的静脉置管？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6c621455480)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934505, encodeId=1c8c1934505b7, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=颠覆抗癌治疗后，免疫疗法能否挽救帕金森病？, objectType=article, longId=209181, objectId=f1c820918173, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1c820918173, replyNumber=0, likeNumber=40, createdTime=2021-07-04, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1c820918173, moduleTitle=颠覆抗癌治疗后，免疫疗法能否挽救帕金森病？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1c820918173)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934506, encodeId=20981934506f2, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=Circulation：蒽环类药物抗癌治疗的同时，需要预防“伤心”吗？, objectType=article, longId=213387, objectId=f83321338ee4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f83321338ee4, replyNumber=0, likeNumber=45, createdTime=2022-05-21, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f83321338ee4, moduleTitle=Circulation：蒽环类药物抗癌治疗的同时，需要预防“伤心”吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f83321338ee4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934504, encodeId=960519345048f, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=Eur Heart J：抗癌治疗引起的心脏毒性分类、患病率和结局, objectType=article, longId=187594, objectId=942418e59497, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=942418e59497, replyNumber=0, likeNumber=62, createdTime=2020-10-10, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=942418e59497, moduleTitle=Eur Heart J：抗癌治疗引起的心脏毒性分类、患病率和结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=942418e59497)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934503, encodeId=a15b193450363, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=「全力推进临床研究，谱写抗癌治疗新篇章」2018中国临床肿瘤学会（CSCO）在厦门隆重召开, objectType=article, longId=149707, objectId=2f02149e0798, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f02149e0798, replyNumber=0, likeNumber=54, createdTime=2019-06-29, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f02149e0798, moduleTitle=「全力推进临床研究，谱写抗癌治疗新篇章」2018中国临床肿瘤学会（CSCO）在厦门隆重召开, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f02149e0798)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934502, encodeId=9467193450245, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=全力推进临床研究，谱写抗癌治疗新篇章——2018 CSCO年会盛大开幕, objectType=article, longId=149209, objectId=50c7149209e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50c7149209e0, replyNumber=0, likeNumber=0, createdTime=2019-01-24, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50c7149209e0, moduleTitle=全力推进临床研究，谱写抗癌治疗新篇章——2018 CSCO年会盛大开幕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50c7149209e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934500, encodeId=ffbe1934500d2, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=Cancer Immunol Res：COX-2抑制剂对抗癌治疗有帮助？, objectType=article, longId=106282, objectId=af9e1062826b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af9e1062826b, replyNumber=0, likeNumber=50, createdTime=2018-05-26, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af9e1062826b, moduleTitle=Cancer Immunol Res：COX-2抑制剂对抗癌治疗有帮助？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af9e1062826b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934501, encodeId=f9f219345012c, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=JAHA：抗癌治疗引起QT间期延长的发生率、诊断和治疗！, objectType=article, longId=122709, objectId=98f6122e099b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98f6122e099b, replyNumber=0, likeNumber=45, createdTime=2018-02-24, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98f6122e099b, moduleTitle=JAHA：抗癌治疗引起QT间期延长的发生率、诊断和治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98f6122e099b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934499, encodeId=d8f41934499aa, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=Lancet Oncol：乳腺癌和肺癌患者全身抗癌治疗后30天死亡率研究, objectType=article, longId=76929, objectId=7de1e6929db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7de1e6929db, replyNumber=0, likeNumber=37, createdTime=2016-09-26, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7de1e6929db, moduleTitle=Lancet Oncol：乳腺癌和肺癌患者全身抗癌治疗后30天死亡率研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7de1e6929db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934497, encodeId=a323193449e6b, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=NEJM：美国精准免疫抗癌治疗取得重要突破, objectType=article, longId=51571, objectId=40e1515e195, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40e1515e195, replyNumber=0, likeNumber=45, createdTime=2015-10-23, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40e1515e195, moduleTitle=NEJM：美国精准免疫抗癌治疗取得重要突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40e1515e195)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934498, encodeId=55d3193449867, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=Wnt信号通路指导的抗癌治疗, objectType=article, longId=57063, objectId=e9505e0634b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9505e0634b, replyNumber=0, likeNumber=44, createdTime=2016-03-19, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9505e0634b, moduleTitle=Wnt信号通路指导的抗癌治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9505e0634b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934496, encodeId=983119344964b, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=怎样解决抗癌治疗引发消化道问题？, objectType=article, longId=9281, objectId=43b492817c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43b492817c, replyNumber=0, likeNumber=49, createdTime=2013-04-25, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43b492817c, moduleTitle=怎样解决抗癌治疗引发消化道问题？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43b492817c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934494, encodeId=4ced193449486, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=Nat Med：去泛素酶USP15是潜在抗癌治疗靶标, objectType=article, longId=4107, objectId=7a1c410ef6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a1c410ef6, replyNumber=0, likeNumber=45, createdTime=2012-08-19, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a1c410ef6, moduleTitle=Nat Med：去泛素酶USP15是潜在抗癌治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a1c410ef6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934493, encodeId=72b2193449396, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=靶向抗癌治疗方法(斯坦福大学公开课), objectType=article, longId=3629, objectId=09ed3629a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09ed3629a2, replyNumber=0, likeNumber=35, createdTime=2012-06-10, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09ed3629a2, moduleTitle=靶向抗癌治疗方法(斯坦福大学公开课), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09ed3629a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934495, encodeId=d33a19344953e, content=<a href='/topic/show?id=27c85552e65' target=_blank style='color:#2F92EE;'>#抗癌治疗#</a>, objectTitle=第10届国际靶向抗癌治疗大会在阿姆斯特丹召开, objectType=article, longId=4299, objectId=61b6429988, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61b6429988, replyNumber=0, likeNumber=36, createdTime=2012-09-16, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61b6429988, moduleTitle=第10届国际靶向抗癌治疗大会在阿姆斯特丹召开, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61b6429988)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗癌治疗

2020-05-29

医者仁心 (审核中...)

前往app查看评论内容

#抗癌治疗#

Brit J Cancer：抗癌治疗与儿童癌症幸存者表观基因组变化有关

2022-04-20

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

ESMO Open：接or不接？对于抗癌治疗患者，BNT162b2 COVID-19疫苗效果如何？

2022-03-17

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

Eur J Cancer：实体癌患者抗癌治疗期间接种BNT162b2疫苗的有效性和安全性

2022-06-15

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

Lancet：如何选择抗癌治疗时的静脉置管？

2021-10-20

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

颠覆抗癌治疗后，免疫疗法能否挽救帕金森病？

2021-07-04

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

Circulation：蒽环类药物抗癌治疗的同时，需要预防“伤心”吗？

2022-05-21

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

Eur Heart J：抗癌治疗引起的心脏毒性分类、患病率和结局

2020-10-10

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

「全力推进临床研究，谱写抗癌治疗新篇章」2018中国临床肿瘤学会（CSCO）在厦门隆重召开

2019-06-29

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

全力推进临床研究，谱写抗癌治疗新篇章——2018 CSCO年会盛大开幕

2019-01-24

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

Cancer Immunol Res：COX-2抑制剂对抗癌治疗有帮助？

2018-05-26

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

JAHA：抗癌治疗引起QT间期延长的发生率、诊断和治疗！

2018-02-24

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

Lancet Oncol：乳腺癌和肺癌患者全身抗癌治疗后30天死亡率研究

2016-09-26

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

NEJM：美国精准免疫抗癌治疗取得重要突破

2015-10-23

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

Wnt信号通路指导的抗癌治疗

2016-03-19

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

怎样解决抗癌治疗引发消化道问题？

2013-04-25

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

Nat Med：去泛素酶USP15是潜在抗癌治疗靶标

2012-08-19

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

靶向抗癌治疗方法(斯坦福大学公开课)

2012-06-10

fyxzlh (审核中...)

前往app查看评论内容

#抗癌治疗#

第10届国际靶向抗癌治疗大会在阿姆斯特丹召开

2012-09-16

科室
- - 订阅+
  - 更多科室
工具
服务